Cadrenal Therapeutics CVKD
NASDAQ CVKD
$0.99 -0.03 (-3.42%)
As of: Oct 22, 2026 · 12:01 PM EDT

Cadrenal Therapeutics (CVKD) Convertible Debt (2022)

Updated

Cadrenal Therapeutics (CVKD) reported Convertible Debt of $110,380 for Q4 2022.

Analysis

Cadrenal Therapeutics (CVKD) Convertible Debt (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.71 Bn 1,141.30 Bn 19.71 Bn
2 Johnson & Johnson 643.11 Bn 561.64 Bn 17.26 Bn
3 AbbVie 502.25 Bn 475.37 Bn 12.70 Bn
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn
5 Novartis Ag 302.74 Bn 266.73 Bn 11.24 Bn
6 Astrazeneca 268.89 Bn 242.58 Bn 12.86 Bn
7 Amgen 242.17 Bn 197.57 Bn 7.24 Bn
8 Gilead Sciences 193.67 Bn 167.87 Bn 6.22 Bn
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn
10 Cadrenal Therapeutics 2.87 Mn -9.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 110,380.00
API Access

Cadrenal Therapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=CVKD&period=max&api_key=YOUR_API_KEY